Reliability and validity of the Arabic version of cluster headache impact questionnaire in both active episodic and chronic cluster headache

阿拉伯语版丛集性头痛影响问卷在活动性发作性丛集性头痛和慢性丛集性头痛中的信度和效度

阅读:1

Abstract

BACKGROUND: Clinical evaluation of cluster headache (CH) impact on patients' quality of life is crucial in research and clinical practice. To our knowledge, none of the measures that evaluated CH-related disability were validated in Arabic. This study aimed to evaluate the reliability and validity of the Arabic version of Cluster Headache Impact Questionnaire (CHIQ) in both active episodic CH (eCH) and chronic CH (cCH). METHODS: Patients with active eCH or cCH were requested to answer the Arabic version of CHIQ, Depression, anxiety and stress scale- 12 (DASS-12), and Short form-12 health survey (SF-12). Cronbach's α and intraclass correlation coefficient (ICC) were used to assess the test reliability. Convergent validity and Explanatory factor analysis of CHIQ items were also assessed. RESULTS: Seventy-two patients with active eCH and another 16 with cCH were evaluated. Patients with cCH had a significantly higher median value of CHIQ total score in comparison to those with eCH (P-value < 0.001). No ceiling or floor effects were detected in CHIQ total score. The Arabic version of CHIQ showed excellent reliability (Cronbach's α = 0.901). The intraclass correlation coefficient of CHIQ total score was 0.983 indicating excellent test re-test reliability. The CHIQ scores were significantly correlated with scores of DASS-12 (r = 0.477) and SF-12 (r=-0.691), supporting the convergent validity of the scale. Exploratory factor analysis revealed two factors labelled as "physical and cognitive impact" and "psychological impact" factors. CONCLUSION: Arabic version CHIQ is a reliable and valid tool for measuring CH-related disability and quality of life in patients with eCH and cCH.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。